CLOSE X

GLAXOSMITHKLINE PHARMACEUTICALS LTD.

NSE : GLAXOBSE : 500660ISIN CODE : INE159A01016Industry : Pharmaceuticals & DrugsHouse : Glaxosmithkline - MNC
BSE2491.55-30.15 (-1.2 %)
PREV CLOSE ( ) 2521.70
OPEN PRICE ( ) 2520.70
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 3084
TODAY'S LOW / HIGH ( )2480.10 2555.00
52 WK LOW / HIGH ( )2220 3515.95
BSE
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 13-11 1924
Management Info
Renu Sud Karnad - Chairman Bhushan Akshikar - Managing Director
Registered Office

Address Gsk House, Dr. Annie Besant Road,Worli,,
Mumbai,
Maharashtra-400030

Phone 022-24959595

Email askus@gsk.com / in.investorquery@gsk.com

Website www.gsk-india.com

Registrars Details
K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.)
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad
Listing : BSE, NSE
NEWS
07Mar GlaxoSmithKline Pharmaceuticals inform
GlaxoSmithKline Pharmaceuticals has informed that the Company has receiv..
02Mar GlaxoSmithKline Pharmaceuticals inform
In compliance with Regulation 30 of Securities and Exchange Board of Ind..
02Mar Appointment of Director
Inter alia, have approved the appointment Mr. Ronojit Biswas (DIN 076848..
23Feb GlaxoSmithKline Pharmaceuticals infor
GlaxoSmithKline Pharmaceuticals has informed that the Company has receiv..
03Feb GlaxoSmithKline Pharmaceuticals inform
Pursuant to Regulation 30 read with para A of Part A of Schedule III of..
Financials
Rs. in Millions
QTR Dec 25 ANNUAL 25
Net Profit2771.89190.6
Gross Profit 3778.9 12484.4
Operating Profit 399413118.5
Net Sales 10225.937234.9
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Alkem Laboratories (BSE)
 5619.05 (2.91%)
M.Cap ( in Cr)67184.17
Astrazeneca Pharma I (BSE)
 8801.65 (1.49%)
M.Cap ( in Cr)22004.13
Fredun Pharma (BSE)
 1690.95 (7.18%)
M.Cap ( in Cr)907.37
Glenmark Pharma (BSE)
 2228.25 (5.26%)
M.Cap ( in Cr)62881.40
NGL Fine-Chem (BSE)
 2355.35 (4.68%)
M.Cap ( in Cr)1455.14
Shareholding Pattern
PROMOTERS 75%
NON-INSTITUTION 12.66%
MUTUAL FUNDS/UTI 4.77%
FI/BANKS/INSURANCE 2.67%
GOVERNMENT 0%
FII 0%

Badjate Stock & Shares Pvt. Ltd.
201, Mangalam Arcade,
Above Venus Book Centre, Dharampeth Extn. Nagpur - 440010 Maharashtra, India.

Advisory for Investors Complaints Data February 2026 Broking Complaints Data February 2026 DP

Filing complaints on SCORES Easy & quick

  • > Register on SCORES portal(https://scores.sebi.gov.in/)
  • > Mandatory details for filing complaints on SCORES
    • Name
    • PAN
    • Address
    • Mobile Number
    • E-mail ID
  • > Benefits:
    • Effective communication
    • Speedy redressal of the grievances
Process Flow of Complaint Redressal Mechanism

Details of Client Bank account of Badjate Stock & Shares Private Limited:

  • 1)Client Bank account Number : 01020340001341 / 57500000546632
  • 2)Name of Bank Account :
    BADJATE STOCK AND SHARES PRIVATE LIMITED - USCNB Account
  • 3)IFSC : HDFC0000102
  • 4)BRANCH : Shankar Nagar / Dharampeth Extn Nagpur
  • 5)MICR – 440240002

Dear Investor,
As you are aware, under the rapidly evolving dynamics of financial markets, it is crucial for investors to remain updated and well-informed about various aspects of investing in securities market. In this connection, please find a link to the BSE Investor Protection Fund website where you will find some useful educative material in the form of text and videos, so as to become an informed investor.
https://www.bseipf.com/investors_education.html We believe that an educated investor is a protected investor !!!

ATTENTION INVESTORS| KYC | IPO | CLIENT BANK A/C| DIRECT ON-BOARDING FOR PMS SERVICES

© Badjate Group 2018

Designed, Developed & Content Powered by  Accord Fintech Pvt. Ltd.